- The ASX200 is trading 0.73% lower today at 7225.60 after lunch.
- Volpara Health Technologies signed its biggest deal to date, with Akumin.
- Creso Pharma rallies today after receiving $800k in new purchase orders.
The Australian market is trading 0.73% lower today at 7225.60 after lunch, taking lead from Wall Street?s turbulent session overnight. Tech stocks are leading losses today, followed by Consumer Discretionary stocks.
The tech stock tumble today on the ASX is driven by Afterpay plunging more than 5%, while Tyro Payments, Nearmap, Altium and Appen each trade more than 4% lower.
Bitcoin is trading 3.40% higher over the last 24-hours at US$49,322.15 at 2pm AEDT.
Shares in Volpara Health Technologies are being dragged down in the broad market sell-off despite the medical imaging software company announcing it has signed its biggest contract to date with Akumin, the leading US outpatient diagnostic imaging provider. Under the 5-year, US$2.15m deal, Volpara will provide Akumin with its Patient Hub software across its network of 170 imaging centres.
Making headlines, Creso Pharma is rallying today after announcing that its wholly-owned Canadian subsidiary, Mernova Medicinal Inc, has received a number of purchase orders worth $800,000. In further positive news, 14 new strains of the company?s product range have been developed under Creso?s Ritual Greens brand with anticipation of sales for these products to come in the near future.
And Xbox is expanding its usability to cater for users with limited mobility by introducing a new accessibility feature to its online stores telling users which products have accessibility features embedded.